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We recently found that the estimated central blood volume (ECBV, i.e., blood volume in the heart cavities, lungs and central arterial tree) is decreased in patients with cirrhosis (1, 2) , indicating a reduced "effective" blood volume. It has been postulated that central hypovolemia is responsible for the activation of the sympathetic nervous system and alterations in other homeostatic regulators, including atrial natriuretic factor (ANF), in these patients (3-7), but no study has addressed that question directly.
Systemic and splanchnic hemodynamic values are altered during p-adrenergic blockade: reductions in portal venous pressure and cardiac output and increases in peripheral vascular resistance and right atrial pressure are seen. Because the ECBV may be determined with these variables (1, 2) , we decided to measure ECBV after propranolol intake.
This study was undertaken to assess the relationship between ECBV, systemic and portal hemodynamica and markers of overall and renal sympathetic nervous activity. We measured the ECBV and the circulating and renal venous levels of norepinephrine, arterial epinephrine and ANF before and after p-adrenergic blockade in patients with cirrhosis and esophageal varices who were undergoing hemodynamic investigation.
PATIENTS AND METHODS
Study Populution. Nineteen patients (17 men) with biopsyverified cirrhosie were referred for hernodynamic i n dgation. All one. The age range was 30 to 69 yr (mean = 58 yr). None of the patients had encephalopathy worse than grade 1. All were abstaining from alcohol intake and were without withdrawal symptoms at the time of study. Six patients were in Child-Turcotte group A, eight were in group B and five were in group C. Ultrasonography showed the presence of ascites in 11 patients. Patients without ascites had no dietary restrictions, whereas those with ascites were prescribed a 40 mmol sodiumlday diet. In the group of patients with ascites, 11 received spironolactone (100 mg/day), as monotherapy in 1 and in combination with bumetanide, 1 to 8 mglday, in 10.
Biochemical test values are summarized in Table 1 . The mean height was 170 cm (range = 163 to 182 cm), the mean body weight was 68 kg (range = 54 to 85 kg) and the mean body surface area was 1.82 m2 (range = 1.61 to 2.18 m2).
Sixteen subjects (12 men) who were without abnormal findings (normal volunteers, n = 3; functional heart murmur, n = 3) or had only minor disorders (fatty liver, n = 8; fibrosis without cirrhosis, n = 2) served as controls for ECBV determination (2). The control patients were fitted with catheters to rule out organic heart disease or portal venous hypertension. None showed evidence of organ failure or fluid accumulation, and all had normal chest appearance on x-ray, normal EKGs and normal levels of serum creatinine and electrolytes. Their age range was 37 to 76 yr, their body height range was 160 to 180 cm, their body weight range was 42 to 99 kg and their body surface area range was 1.40 to 2.17 m2.
Nine other subjects served as controls for assay of arterial and renal venous catecholamines (eight were men; six of these subjects were normal volunteers, two had fatty liver and one had a functional heart murmur). Their ages ranged from 22 to 52 yr (5) . The controls for assay of circulating ANF were eight people (four women) with no abnormal hernodynamic findings (three had irritable bowel syndrome and one each had intercostal neuralgia, myositis, postcholecystedomy pain and persistent hepatitis and fatty liver); they were fitted with catheters to rule out portal hypertension or mesenteric ischemia. Their ages ranged from 48 to 68 yr. All subjects consented to the study, which was approved by the Ethics Committee for Medical Research in Copenhagen. No complications or side effects were encountered. h t o c o l . Cardiac output, plasma volume, blood volume, pressure measurements and assessment of ECBV were performed as specified in the following paragraphs. The "ideal" body weight (IBW), expressed in kilograms of IBW (kg*), was estimated as
where H is body height in centimeters (8).
Plasma samples for determination of endogenous norepinephrine, epinephrine and ANF were obtained as described elsewhere (1, 5, 7) .
The above procedures were performed in a basal period and were repeated during p-adrenergic blockade 90 min after ingestion of propranolol (80 mg). As a control of the time courses of arterial norepinephrine and epinephrine levels, ANF and ECBV, these variables were determined twice with the same time interval in other cirrhotic patients who were not receiving propranolol but were otherwise undergoing the same catheterization procedure. No significant changes were found.
Catheterization. All subjects were studied in the morning after overnight fasting and after at least 1 hr in the supine position. Catheterization of the right atrium and the hepatic and renal veins was performed as described earlier (2, 5). A Cournand catheter (USCI; C.R. Bard Ireland Ltd., Galway, Ireland) or Swan-Ganz catheter (7F) (Baxter Healthcare Corp., Irvine, CA) was guided to the right atrium and hepatic and renal veins through the femoral route under fluoroscopic control while the patient was under local anesthesia. An indwelling polyethylene catheter was introduced through the femoral artery by the Seldinger technique, and the catheter tip was placed at the aortic bifurcation. Pressures were measured with a capacitance transducer (Simonsen & Weel, Copenhagen, Denmark). The zero reference was the midaxillary level.
Determination of Flow and Volume. Total plasma volume, whole blood volume, and cardiac output were determined as described elsewhere (1,2). ECBV was assessed according to the kinetic theory as cardiac output multiplied by the mean indicator transit time (1,2, 9-11). The latter is the mean time of indicator sojourn in the central vascular bed (9), determined as the time-weighted area under the arterial indicator curve and correded for the arterial catheter transit time (1, 2) . Vol. 16, No. 5, 1992 CENTRAL BLOOD VOLUME IN CIRRHOSIS 1165 Data expressed as mean t S.D.; *expressed per kg estimated ideal body weight.
Catheter transit time was determined as catheter volume divided by catheter flow rate during blood sampling (0.5 d s e c ) (2).
As indicator, 5 pCi of 1261-labeled human serum albumin (Institute of Energy Technique, yjeller, Norway) was injected quantitatively as a bolus through the venous catheter while the tip waa located at the junction of the right atrium and the inferior vena cava. Arterial samples (500 ~1 ) were collected with a calibrated pump (Dich, Copenhagen, Denmark) every second for 60 sec. Standards and blood samples were counted in a well-type scintillation counter (LKB-Wallace, Stockholm, Sweden); at least 10,000 counts were recorded per sample. The coefficient of variation of duplicate determination of ECBV in six cirrhotic patients was 8.8% (2).
Plaama Catecholamines. Blood samples were collected from an artery and the right renal vein in ice-chilled tubes containing EGTA. Plasma was separated immediately from cells by centrifugation at 4" C and stored at -70" C until it could be assayed. Plasma concentrations of endogenous norepinephrine and epinephrine were determined with an enzymatic isotope derivative technique described previously (12). The intraassay and interassay coefficients of variation were approximately 7% and 11% for norepinephrine and epinephrine, respectively.
ANF. Blood samples (10 ml) were collected from an artery into iaAdled tubes containing aprotinin (5,000 KTU) and heparin (500 IU). Plasma was immediately separated from blood cells by centrifugation at 4" C and frozen ( -25" C) until it could be assayed. ANF in plasma was determined on RIA as described elsewhere (13, 14) . The intraassay and interassay coefficients of variation were less than 10% and 15%, respectively.
stati.tiwl &whation. Paired and unpaired Student's t teats and one-way ANOVA were used for group comparisons.
Correlations were performed according to the least-squares method; p < 0.05 was considered significant.
RESULTS

Boecrl period.
Results of assays for ECBV and other hernodynamic variables are summarized in Table 2 . The ECBV and mean transit time of the central circulation were significantly decreased in patients with cirrhosis compared with controls (ECBV mean = 22.9 mvkg* in cirrhotic patients vs. 27.2 mVkg* in controls, p < 0.05; mean transit time: 14 sec in cirrhotic patients vs. 20 sec in controls, p < 0.005). The patients taking diuretic drugs had a slightly smaller mean ECBV than did those patients who were not taking diuretic drugs, but this difference was not statistically significant (22.0 2 1.2 mvkg* (S.E.M.) vs. 24.2 2 1.9 ml/kg*, respectively; NS). ECBV was inversely correlated with increased hepatic venous pressure gradient in the patients (r = -0.62, p < 0.01; Fig. 1) . Total plasma volume and cardiac output were increased, whereas mean arterial blood pressure and systemic vascular resistance were decreased in the patient group ( Table 2) . Table 3 , arterial plasma norepinephrine levels were significantly increased in patients compared with levels in controls (3.08 nmoUL vs. 1.36 nmoVL; p < 0.01). The mean renal venous norepinephrine concentration in the cirrhotic patients was significantly higher than the mean arterial concentration (4.26 n m o n vs. 3.08 nmoVL; n = 18, p < 0.001) and significantly higher than the mean r e d venous norepinephrine level in the controls (4.26 nmoVL vs. 1.78 nmoVL; p < 0.01). The cirrhotic patients had a mean arterial norepinephrine level that was inversely correlated with ECBV (r = -0.54, p < 0.01; Fig. 2A) ; patients with normal arterial values of norepinephrine (i.e., less than 2.2 nmoVL; n = 8) had a significantly higher mean ECBV than did patients with increased norepinephrine levels (26.3 2 1.7 vs. 21.4 2 0.9; n = 11, p < 0.02). Renal venous norepinephrine level was also inversely correlated with ECBV in the patient group (r = -0.53, n = 18, p < 0.02; Fig. 2B) . Plasma epinephrine and ANF levels were normal in our cirrhotic patients ( Table 31 , and no significant relationship was found between ECBV and ANF concentration (r = 0.18, NS; Fig. 3) or epinephrine level. pAdrenergic Blockade. p-Adrenergic blockade produced a substantial decrease in heart rate and cardiac respectively; Table 4 ). The mean transit time of the central circulation increased significantly (+28%; p < 0.005), but the mean ECBV was not altered significantly after propranolol ingestion, except in six patients. These patients had a decrease in mean arterial blood pressure (from 85 mm Hg to 69 mm Hg) and a decrease in mean ECBV (from 23.2 ml/kg* to 20.6 m&$; p < 0.05). The mean hepatic venous pressure gradient decreased (from 18.6 to 16.3 mm Hg; n = 19, p < 0.011, but no significant correlation with ECBV was observed during p-adrenergic blockade. This change was positively correlated with the change in ECBV (r = 0.44, p = 0.06). Arterial norepinephrine and epinephrine levels increased significantly &r propranolol ingestion (Table  41 , but no significant correlation with ECBV was found. ANF did not change significantly and was not correlated with ECBV durjng P-adrenergic blockade; nor was any change in M,, norepinephrine or epinephrine level correlated with change in ECBV.
As shown in
DISCUSSION
The arterial plasma level of norepinephrine is an index of overall sympathetic nervous activity in patients with cirrhosis (5, 15-17) . In this study, ECBV was inversely correlated with arterial norepinephrine concentration, which means that the more reduced the ECBV, the more enhanced the sympathetic nervous tone. This relationship may not be causal-for example, ECBV and "Data expressed as mean ? S.D norepinephrine level could both be related to progression of liver disease (5, 18 ). However, it should be borne in mind that a well-established reflex arc links volume receptors and baroreceptors to postganglionic sympathetic burst frequency in humans and animals (19, 20). It is thus likely that central vascular underfilling activates volume receptors and baroreceptors, thereby contributing to the enhanced sympathetic nervous activity found in patients with cirrhosis. Moreover, this study showed a significant inverse correlation between the size of the ECBV and the renal venous norepinephrine level. This finding suggests that the central underfilling contributes directly to enhanced sympathetic activity in the kidneys, because the level of renal venous norepinephrine is closely related to norepinephrine spillover from the kidney and thereby related to the renal sympathetic nervous tone (5,21,22) .
It is now well established that renal sympathetic overactivity contributes to the reduced renal blood flow and increaeed sodium and water retention in patients with decompensated cirrhosis (4, 16, 23) . Effects of diuretic drugs on sympathetic nervous activity and ECBV are modest and have been considered in detail elsewhere (2, 5) .
In contrast to the sigdicant relationship between d e c r e a d ECBV and enhanced sympathetic nervous tone, we found no relationship between ECBV and circulating level of ANF. ANF has been reported to be reduced, normal and increased in the presence of cirrhosis (1, 7, 24-26) . Arterial ANF concentration was normal in this study. Plasma ANF level is increased in patients with congestive heart failure and in subjects with volume expansion and increased atrial pressure (27, 28). It is low or normal in people with hypovolemia (27, 29). The normal ANF levels and the absence of correlation with ECBV found in our patients suggest that atrial volume is not affected substantially by ECBV reduction. This point of view is in keeping with recent reports by Rector et al. (30, 311 , who actually found an insignificant decrease in right atrial volume ( -5 ml) and a significant increase in left atrial volume ( + 16 ml) in patients with cirrhosis. Another possibility is that the presence of ascites alters spatial relationships in the heart (32, 331, thereby rendering the release of ANF more or less independent of the size of ECBV. Furthermore, decreased clearance of ANF in the presence of reduced release may also account for the unchanged plasma concentration. This possibility, however, seem less likely because recent reparts suggest that clearance of ANF is normal in cirrhosis (34, 35) .
The time sequence of the development of abnormal distribution of blood volume in cirrhotic patients is not known. In an experimental model of portal hypertension, Groszmann (36) recently showed that the initial event is reduced systemic vaecular resistance. Cardiac output does not increase until plasma volume expansion has taken place. As further evidence of the importance of peripheral vasodilatation, it should be mentioned that normalization of sodium and water excretion may not only require expansion of the central blood volume but also normalization of the low arterial blood pressure (17). p-Adrenergic blockade induced substantial changes in systemic vascular resistance and portal pressure. The decrease in the hepatic venous pressure gradient and the increase in systemic vascular resistance (both toward normal values) might be expected to cause an increase in ECBV (1, 2) . Propranolol decreased cardiac output and increased right atrial pressure. However, in spite of these major hemodynamic alterations ECBV was almost unchanged and was decreased only in those patients who experienced decreases in mean arterial blood pressure. This indicates to us that arterial blood pressure is an important determinant for the size of ECBV and stresses the fact that ECBV includes the central parts of the arterial tree. Moreover, reduced arterial blood pressure may not only bring about reduced arterial blood volume but also a decrease in the volumes of the heart cavities and vascular bed of the lungs through decreased afterload (37) . Finally, propanolol may modify ECBV by changing the circulating level of vasoactive factors; this may influence central vascular tone (18).
During p-adrenergic blockade, the inverse relationship between ECBV on one hand and hepatic venous pressure gradient, arterial norepinephrine level and renal venous norepinephrine level on the other hand disappeared. This may have been a result of direct action exerted by propranolol on the hepatic venous pressure gradient and on sympathetic nervous activity, whereas the alteration in ECBV may have been governed largely by changes in preload and afterload. A direct relationship was observed between the change in right atrial pressure and the change in ECBV after propranolol ingestion. In a previous study we found no relationship between ECBV size and right atrial pressure (2) . In this context it should be recalled that the level of right atrial pressure relative to an external reference in the midaxillary line does not necessarily reflect the transmural atrial pressure and the filling of the central vascular bed. However, by relating the change in ECBV to the change in right atrial pressure we obtained a measurement independent of the external pressure reference.
Patients with cirrhosis have decreased systemic vascular resistance because of arteriolar dilatation and opening of arteriovenous shunts in almost all vascular territories (4, 38, 39) . The potential effect of these hemodynamic alterations on the assessment of the ECBV is considered in the appendix. As the appendix illustrates, evenly distributed peripheral vasodilatation or arteriovenous shunting in all vascular territories is not likely to influence determination of ECBV. Conversely, the presence of a large central arteriovenous shunt may result in a slightly overestimated value of ECBV. In a previous report, we considered the potential effects of intracardiac shunts and portopulmonary shunting on the determination of ECBV (2). Pulmonary shunts have no effect on the assessment of ECBV (2,40) .
In conclusion, patients with cirrhosis are unable to maintain a normal size of central and arterial blood volume ("effective" blood volume). Reduced central and arterial blood volume most likely "unload" volume receptors and baroreceptors and thus provoke enhanced overall sympathetic nervous activity and increased sympathetic tone in the kidney. p-Adrenergic blockade resulted in substantial hemodynamic changes but only modest changes in the central and arterial blood volume. However, these changes were correlated with alterations in preload and afterload, indicating that central circulatory underfilling is an integral part of the hemodynamic derangement observed in cirrhosis.
